Saudi Chemical Co. (2230.SR) Financials
2230.SR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 4.9 billion | 3.1 billion |
| 2023-09-30 | 5.3 billion | 3.5 billion |
| 2023-06-30 | 5.1 billion | 3.4 billion |
| 2023-03-31 | 4.9 billion | 3.2 billion |
2230.SR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 314.7 million | ? |
| 2023-09-30 | 160.8 million | ? |
| 2023-06-30 | -47.1 million | ? |
| 2023-03-31 | -72.5 million | ? |
2230.SR Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 89.0 million |
| 2023-09-30 | 35.1 million |
| 2023-06-30 | 26.5 million |
| 2023-03-31 | 32.3 million |
2230.SR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 15.7 million |
| 2023-09-30 | - | - | 15.6 million |
| 2023-06-30 | - | - | 15.8 million |
| 2023-03-31 | - | - | 15.9 million |
2230.SR Shares Outstanding
2230.SR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 34.6 million | - | -116.6 million | - |
| 2023-09-30 | 21.3 million | - | 77.7 million | - |
| 2023-06-30 | 16.5 million | - | 78.6 million | - |
| 2023-03-31 | 4.3 million | - | 72.1 million | - |
2230.SR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.4 billion | 1.2 billion |
| 2023-09-30 | 1.2 billion | 1.0 billion |
| 2023-06-30 | 1.2 billion | 1.1 billion |
| 2023-03-31 | 1.0 billion | 887.1 million |
2230.SR
Price: SAR9.03
Dividend Yield: 0.01%
Forward Dividend Yield: 0.55%
Payout Ratio: 22.73%
Dividend Per Share: 0.05 SAR
Earnings Per Share: 0.22 SAR
P/E Ratio: 32.21
Exchange: SAU
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 6.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4